Investigational drugs under study by the United States National Cancer Institute

Cancer Treat Rev. 1976 Mar;3(1):43-60. doi: 10.1016/s0305-7372(76)80016-3.
No abstract available

Publication types

  • Review

MeSH terms

  • Acrylates / therapeutic use
  • Alkylating Agents / therapeutic use
  • Ancitabine / therapeutic use
  • Animals
  • Antibiotics, Antineoplastic / therapeutic use
  • Antimetabolites, Antineoplastic / therapeutic use
  • Antineoplastic Agents / therapeutic use*
  • Azacitidine / therapeutic use
  • Chemical Phenomena
  • Chemistry
  • Chromomycins / therapeutic use
  • Cisplatin / therapeutic use
  • DNA, Neoplasm / metabolism
  • Drug Evaluation, Preclinical
  • Etoposide / therapeutic use
  • Humans
  • Ifosfamide / therapeutic use
  • Leukemia L1210 / drug therapy
  • Mice
  • Mitosis / drug effects
  • National Institutes of Health (U.S.)
  • Neoplasms / drug therapy*
  • Neoplasms, Experimental / drug therapy
  • Razoxane / therapeutic use
  • Tegafur / therapeutic use
  • Teniposide / therapeutic use
  • United States

Substances

  • Acrylates
  • Alkylating Agents
  • Antibiotics, Antineoplastic
  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Chromomycins
  • DNA, Neoplasm
  • Tegafur
  • Razoxane
  • Etoposide
  • Teniposide
  • Ancitabine
  • Azacitidine
  • Cisplatin
  • Ifosfamide